Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436618 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

277

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Lymphoproliferative Disorder

Interventions

DRUG: Everolimus

Sponsor

Mayo Clinic

Collaborators

[object Object]